Register entry

Agios Pharmaceuticals, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
7
Live patents
33
Exclusivities
2
Countries
0
Catalogue

Drug listings by form and route

7

7 active NDC listings: 7 human prescription drug. By marketing category: NDA 7.

Dosage formNDCs
tablet, film coated5
kit2
RouteNDCs
oral5
Labeller name on the listingNDCs
agios pharmaceuticals, inc.7
Exclusivity

Patents and exclusivities

33
PatentProductCoversExpiry
10632114AQVESME, PYRUKYNDmitapivat sulfateuseMay 2032
9682080AQVESME, PYRUKYNDmitapivat sulfateuseMay 2032
9980961PYRUKYNDmitapivat sulfateuseMay 2032
9193701AQVESME, PYRUKYNDmitapivat sulfateuseOct 2032
11793806PYRUKYNDmitapivat sulfateuseApr 2033
RE49582AQVESME, PYRUKYNDmitapivat sulfatesubstance, productApr 2035
11234976PYRUKYNDmitapivat sulfateuseOct 2038
11254652AQVESME, PYRUKYNDmitapivat sulfatesubstance, productNov 2038
11878049AQVESME, PYRUKYNDmitapivat sulfateuseJul 2041
ProductExclusivityUntil
AQVESMEMITAPIVAT SULFATEODE-522 Orphan drugDec 2032
PYRUKYNDMITAPIVAT SULFATEODE-392 Orphan drugFeb 2029
Catalogue

Marketed products

7
BrandGeneric nameForm / routeNDC
AQVESMEmitapivattablet, film coated, oral71334-235NDA
PYRUKYNDmitapivattablet, film coated, oral71334-205NDA
PYRUKYNDmitapivattablet, film coated, oral71334-210NDA
PYRUKYNDmitapivattablet, film coated, oral71334-215NDA
PYRUKYNDmitapivattablet, film coated, oral71334-220NDA
PYRUKYNDmitapivatkit71334-225NDA
PYRUKYNDmitapivatkit71334-230NDA
Enquiry

Common questions

Is Agios Pharmaceuticals, Inc. FDA approved?
Agios Pharmaceuticals, Inc. holds no registered establishment of its own; 7 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Agios Pharmaceuticals, Inc. make?
7 products are listed under Agios Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet, film coated; kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.